EP 1638596 A2 20060329 - USE OF COMPOSITIONS COMPRISING A SOLUBLE FORM OF HLA-G IN THE TREATMENT OF BLOOD DISEASES
Title (en)
USE OF COMPOSITIONS COMPRISING A SOLUBLE FORM OF HLA-G IN THE TREATMENT OF BLOOD DISEASES
Title (de)
VERWENDUNG VON ZUSAMMENSETZUNGEN MIT EINER LÖSLICHEN FORM VON HLA-G BEI DER BEHANDLUNG VON BLUTERKRANKUNGEN
Title (fr)
UTILISATION DE COMPOSITIONS CONTENANT UNE FORME SOLUBLE D' HLA-G DANS LE TRAITEMENT DE PATHOLOGIES DU SANG
Publication
Application
Priority
- FR 2004001663 W 20040629
- FR 0307871 A 20030630
Abstract (en)
[origin: WO2005002617A2] The invention relates to the use of compositions comprising a soluble form of HLA-G in the treatment of blood and circulatory system diseases (anemias and ischaemias).
IPC 1-7
IPC 8 full level
A61K 38/17 (2006.01); A61P 7/06 (2006.01)
CPC (source: EP US)
A61K 38/1774 (2013.01 - EP US); A61P 7/06 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 9/10 (2017.12 - EP)
Citation (search report)
See references of WO 2005002617A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
FR 2856599 A1 20041231; EP 1638596 A2 20060329; JP 2007520428 A 20070726; US 2007020703 A1 20070125; WO 2005002617 A2 20050113; WO 2005002617 A3 20050519
DOCDB simple family (application)
FR 0307871 A 20030630; EP 04767507 A 20040629; FR 2004001663 W 20040629; JP 2006516337 A 20040629; US 56265905 A 20051229